Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology

Molecular Psychiatry

Volumn 6, Issue 4, 2001, Pages 445-449

  Rothermundt, M ^a   Missler, U ^b   Arolt, V ^a   Peters, M ^a   Leadbeater, J ^c   Wiesmann, M ^b   Rudolf, S ^b   Wandinger, K P ^d   Kirchner, H ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c Psychiatric Hospital   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Antipsychotic agents; Negative symptomatology; Nerve tissue protein S100; Psychiatric status; Schizophrenia

Indexed keywords

BENPERIDOL; BROMPERIDOL; CLOZAPINE; FLUPENTIXOL; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PROTEIN S 100; PROTEIN S100B; RISPERIDONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; MACROGLIA; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA; SCORING SYSTEM; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; AUTOANTIGENS; BIOLOGICAL MARKERS; CALCIUM-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PSYCHOLOGICAL TESTS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; S100 PROTEINS; SCHIZOPHRENIA, PARANOID; SCHIZOPHRENIC PSYCHOLOGY; TIME FACTORS;

EID: 0034979240     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000889     Document Type: Article

References (23)

1. Defining the course of brain structural change and plasticity in schizophrenia
2. Schizophrenia as a disorder of developmentally reduced synaptic connectivity
3. 2+ binding protein family
4. Pathophysiologic aspects of S-100beta protein: A new biological marker of brain pathology
5. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease
6. Transgenic mice overexpressing the neurotrophic factor S-100β show neuronal cytoskeletal and behavioral signs of altered aging processes: Implications for Alzheimer's disease and Down's syndrome
7. The S-100: A protein family in search of a function
8. Measurement of S-100 protein in human blood and cerebrospinal fluid: Analytic method and preliminary clinical results
9. S-100 protein: Serum marker of focal brain damage after ischemic territorial MCA infarction
10. Overexpression of the neurotrophic cytokine S100b in human temporal lobe epilepsy
11. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders
12. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction and prognosis in acute ischemic stroke
13. Correlation of computed tomography findings and serum brain damage markers following severe head injury
14. Rapid evaluation of S-100 serum levels. Case report and comparison to previous results
15. Assessment of damage to the central nervous system by determination of S-100 protein in the cerebrospinal fluid
16. S-100 proteins in trimethyltin-induced neurodegeneration in the rat hippocampus. An immunochemical and immunocytochemical study
17. S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage
18. Elevated plasma levels of S-100b protein in schizophrenic patients
19. Decreased S100B protein in schizophrenia: Preliminary evidence
20. Neuropsychological function in patients with increased serum levels of protein S-100 after minor head injury
21. Abnormal exploratory behavior in transgenic mice carrying multiple copies of the human gene for S100 beta
22. Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia
23. Perspectives in S-100 protein biology